Registration Link – Contact Details
Dear Doctor,Thank you for your interest in registering for this Hybrid event Contact Details First Name Last Name Email Address …
Related Articles
Episódio 16 – O desafio da epidemia global de obesidade e opções terapêuticas para enfrentá-lo by DA Podcast
Tema: O desafio da epidemia global de obesidade e opções terapêuticas para enfrentá-lo Apresentado por: Dr. Sergio Emanuel Kaiser – Coordenador de Relações Internacionais e…
Effects of Cuff Size on the Accuracy of Blood Pressure Readings
This randomized crossover trial aims to determine the effect of using a regular blood pressure cuff vs an appropriately sized blood pressure cuff on automated…
Dólar abre em queda nesta terça-feira
Principal índice da bolsa de valores subiu 0,68%, aos 131.084 pontos, novo recorde histórico. Já a moeda norte-americana caiu 0,65%, cotada a R$ 4,9047.
Bayer cancels asundexian phase III study program
Germany’s Bayer AG said on Sunday it is cancelling a phase III study program to investigate the efficacy and safety of asundexian, an oral Factor…
Javier Milei é eleito presidente da Argentina com pauta ultraliberal e discurso radical antipolítica
Economista venceu Sergio Massa no 2º turno e tomará posse em dezembro para 4 anos de mandato. Entre suas propostas estão dolarizar a economia e…
European Atherosclerosis Society on LinkedIn: With just a little more than a week to go, make sure to sign up for our…
With just a little more than a week to go, make sure to sign up for our upcoming webinar on November 15. Dr Peter Libby…
Tashager Araro (@blackjewishmagic) • Instagram reel
1,594 likes, 143 comments – blackjewishmagic on November 4, 2023: “Am Yisrael Chai”
Effects of Cuff Size on the Accuracy of Blood Pressure Readings
This randomized crossover trial aims to determine the effect of using a regular blood pressure cuff vs an appropriately sized blood pressure cuff on automated…
WorldHeartDayPublic – Contact Details
Contact Details الاسم الأول اسم العائلة الوظيفة مكان العمل البريد الإلكتروني رقم الهاتف المحمول …
Anthos Therapeutics on LinkedIn: Atrial Fibrillation Study Shows Overwhelming Benefit for Abelacimab vs…
#NEWS: Anthos Therapeutics today announced that the AZALEA TIMI-71 atrial fibrillation study with the dual-acting Factor XI / XIa inhibitor, abelacimab, was…